Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 85


Thinking about the thoughts of others; temporal and spatial neural activation during false belief reasoning.

Mossad SI, AuCoin-Power M, Urbain C, Smith ML, Pang EW, Taylor MJ.

Neuroimage. 2016 Jul 1;134:320-7. doi: 10.1016/j.neuroimage.2016.03.053. Epub 2016 Mar 30.


Impact of Video Education on Influenza Vaccination in Pregnancy.

Goodman K, Mossad SB, Taksler GB, Emery J, Schramm S, Rothberg MB.

J Reprod Med. 2015 Nov-Dec;60(11-12):471-9.


Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients.

Mani S, Rybicki L, Jagadeesh D, Mossad SB.

Bone Marrow Transplant. 2016 May;51(5):713-7. doi: 10.1038/bmt.2015.311. Epub 2016 Jan 4.


Primary Cytomegalovirus Syndrome: An Unexpected Cause of Donor Morbidity Shortly After Right Lobectomy for Living-Donor Liver Transplant.

Mossad SB, Quintini C.

Exp Clin Transplant. 2015 Jul 2. doi: 10.6002/ect.2015.0044. [Epub ahead of print]


A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.

Stadtmauer EA, Sullivan KM, Marty FM, Dadwal SS, Papanicolaou GA, Shea TC, Mossad SB, Andreadis C, Young JA, Buadi FK, El Idrissi M, Heineman TC, Berkowitz EM.

Blood. 2014 Nov 6;124(19):2921-9. doi: 10.1182/blood-2014-04-573048. Epub 2014 Sep 18.


Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.

Tavadze M, Rybicki L, Mossad S, Avery R, Yurch M, Pohlman B, Duong H, Dean R, Hill B, Andresen S, Hanna R, Majhail N, Copelan E, Bolwell B, Kalaycio M, Sobecks R.

Bone Marrow Transplant. 2014 Oct;49(10):1310-6. doi: 10.1038/bmt.2014.150. Epub 2014 Aug 11.


Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Jr CS, Koval CE, van Duin D, de Morais AG, Gonzalez BE, Avery RK, Mawhorter SD, Brizendine KD, Cober ED, Miranda C, Shrestha RK, Teixeira L, Mossad SB.

World J Transplant. 2014 Jun 24;4(2):43-56. doi: 10.5500/wjt.v4.i2.43. Review.


Prevention and treatment of influenza in the primary care office.

Golovyan DM, Mossad SB.

Cleve Clin J Med. 2014 Mar;81(3):189-99. doi: 10.3949/ccjm.81a.13159.


Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.

Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB.

Clin J Am Soc Nephrol. 2014 Mar;9(3):553-61. doi: 10.2215/CJN.08420813. Epub 2014 Jan 9.


Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.

Taimur S, Askar M, Sobecks R, Rybicki L, Warshawsky I, Mossad S.

Transpl Infect Dis. 2014 Feb;16(1):61-6. doi: 10.1111/tid.12163. Epub 2013 Nov 20.


Improvement in the outcome of invasive fusariosis in the last decade.

Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P, Carlesse F, Queiroz-Telles F, Sheppard DC, Kindo A, Cesaro S, Hamerschlak N, Solza C, Heinz WJ, Schaller M, Atalla A, Arikan-Akdagli S, Bertz H, Galvão Castro C Jr, Herbrecht R, Hoenigl M, Härter G, Hermansen NE, Josting A, Pagano L, Salles MJ, Mossad SB, Ogunc D, Pasqualotto AC, Araujo V, Troke PF, Lortholary O, Cornely OA, Anaissie E.

Clin Microbiol Infect. 2014 Jun;20(6):580-5. doi: 10.1111/1469-0691.12409. Epub 2013 Nov 18.


CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H, Boeckh M; CMX001-201 Clinical Study Group.

N Engl J Med. 2013 Sep 26;369(13):1227-36. doi: 10.1056/NEJMoa1303688.


CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.

Elfadawy N, Flechner SM, Liu X, Schold J, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB.

Transplantation. 2013 Dec 27;96(12):1097-103. doi: 10.1097/TP.0b013e3182a6890d.


Epidemiology and risk factors for infections in myelodysplastic syndromes.

Sullivan LR, Sekeres MA, Shrestha NK, Maciejewski JP, Tiu RV, Butler R, Mossad SB.

Transpl Infect Dis. 2013 Dec;15(6):652-7. doi: 10.1111/tid.12130. Epub 2013 Sep 9.


A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.

Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D.

Transpl Infect Dis. 2013 Oct;15(5):487-92. doi: 10.1111/tid.12116. Epub 2013 Jul 25.


Disseminated adenoviral infection masquerading as lower urinary tract voiding dysfunction in a kidney transplant recipient.

Aboumohamed A, Flechner SM, Chiesa-Vottero A, Srinivas TR, Mossad SB.

Clin Nephrol. 2014 Nov;82(5):332-6. doi: 10.5414/CN107977.


The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.

Elfadawy N, Flechner SM, Liu X, Schold J, Tian D, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB.

Transpl Int. 2013 Aug;26(8):822-32. doi: 10.1111/tri.12134. Epub 2013 Jun 14.


Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.

Cuellar-Rodriguez J, Stephany B, Poggio E, Mossad SB, Goldfarb D, Lard M, Askar M, Fatica R, Srinivas T, Braun W, Shoskes D, Flechner S, Schmitt SK, Shrestha R, Avery RK.

Clin Transplant. 2013 May-Jun;27(3):E230-6. doi: 10.1111/ctr.12110. Epub 2013 Apr 3.


2012-2013 influenza update: hitting a rapidly moving target.

Jin XW, Mossad SB.

Cleve Clin J Med. 2012 Nov;79(11):777-84. doi: 10.3949/ccjm.79a.12151.


Fatal human metapneumovirus and influenza B virus coinfection in an allogeneic hematopoietic stem cell transplant recipient.

Ghattas C, Mossad SB.

Transpl Infect Dis. 2012 Oct;14(5):E41-3. doi: 10.1111/j.1399-3062.2012.00766.x. Epub 2012 Jul 23.

Items per page

Supplemental Content

Loading ...
Support Center